Original article: A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer

Annals of Oncology

Volumn 1, Issue 2, 1990, Pages 128-133

  Sculier, J P ^a   Klastersky, J ^a   Libert, P ^a   Ravez, P ^a   Thiriaux, J ^a   Lecomte, J ^a   Bureau, G ^a   Vandermoten, G ^a   Dabouis, G ^a   Michel, J ^a   Schmerber, J ^a   Sergysels, R ^a   Becquart, D ^a   Mommen, P ^a   Paesmans, M ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Chemotherapy; Cisplatin; Small cell lung cancer

Indexed keywords

CISPLATIN; ETOPOSIDE; VINDESINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CISPLATIN; COMPARATIVE STUDY; ETOPOSIDE; FEMALE; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGE; SURVIVAL RATE; VINDESINE;

EID: 0025309997     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a057690     Document Type: Article

References (19)

1. Aisner J. Alberto P. Bitran J. Role of chemotherapy in small cell lung cancer. A consensus report of the International Association for the Study of Lung Cancer Workshop Cancer Treat Rep 67 1983 37 43
2. Sculier J.-P. Klastersky J. Intensive chemotherapy in small cell lung cancer Eur J Cancer Clin Oncol 22 1986 1417 1420
3. Allan S.O. Gregor A. Combleet M.A. Phase II trial of vindesine and VP16-213 in the palliation of poor prognosis patients and elderly patients with small cell lung cancer Cancer Chemother Pharmacol 13 1984 106 108
4. Kaplan E.L. Meier P. Non parametric estimation from incomplete observations Am Stat Assoc J 53 1958 457 481
5. Peto R. Pike M.C. Armitage P. Design and analysis of randomized trials requiring prolonged observation of each patient II. Analysis and examples Br J Cancer 35 1977 1 39
6. Cox D.R. Oakes D. Analysis of survival data 1984 Chapman and Hall London/New York
7. Edmonson J.H. Lagakos S.W. Selawry O.S. Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung Cancer Treat Rep 60 1976 925 932
8. Hansen H.H. Dombemowsky P. Hansen M. Chemotherapy of advanced small–cell anaplastic carcinoma. Superiority of a 4 drug combination to a three drug combination Ann Intern Med 89 1978 177 181
9. Maurer L.H. Tulloh M. Weiss R.B. A randomized combined modality trial in small cell carcinoma of the lung. Comparison of combination chemotherapy-radiation therapy versus cyclophos-phamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation Cancer 45 1980 30 39
10. Ettinger D.S. Lagakos S. Phase III study of CCNU, cyclophos-phamide, adriamycin, vincristine, and VP16 in small-cell carcinoma of the lung Cancer 49 1982 1544 1554
11. Jackson O.V. Zekan P.J. Caldwell R.D. VP-16-213 in combination chemomerapy with chest irradiation for small-cell lung cancer: A randomized trial of the Piedmont Oncology Association J Clin Oncol 2 1984 1343 1351
12. Lowenbraun S. Birch R. Buchanan R. Combination chemotherapy in small cell lung carcinoma. A randomized study of two intensive regimens Cancer 54 1984 2344 2350
13. Zhiyi Z. Shenzhong W. Xiafang Z. Small-cell carcinoma of the lung: Results of combination chemotherapy and radiation therapy (COF vs COFP randomized analyzed) Int J Radial Oncol Biol Phys 10 1984 2139 2143
14. Messeih A.A. Schweitzer J.M. Lipton A. Addition of etoposide to cyclophosphamide, doxorubicin and vincristine for remission induction and survival in patients with small cell lung cancer Cancer Treat Rep 71 1987 61 66
15. Jackson D.J. Cruz J. White D. Cisplatin in extensive small cell lung cancer A randomized trial by the Piedmont Oncology Association Proc ASCO 8 1989 222
16. Morgan D.A. Gilson D. Fletcher J. Vincristine and etoposide: An effective chemotherapy regimen with reduced toxicity in extensive small cell lung cancer EurJ Cancer Clin Oncol 23 1987 619 621
17. Evans W.K. Shepherd F.A. Feld R. VP-16 and cisplatin as first-line therapy for small cell lung cancer J Clin Oncol 3 1985 1471 1477
18. Boni C. Cocconi G. Bisagni G. Cisplatin and etoposide (VP-16) as a single regimen for small cell lung cancer A phase II trial Cancer 63 1989 638 642
19. Sculier J.-P. Klastersky J. Becquart D. Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancer Eur J Cancer Clin Oncol 24 1988 519 526